Fungal Endogenous Endophthalmitis during Pregnancy as a Complication of In-Vitro Fertilization

被引：2

作者：

Hasanreisoglu, Murat ^{[1
,2
]}

Mahajan, Sarakshi ^{[2
]}

Ozdemir, Huseyin Baran ^{[3
]}

Ozdal, Pinar Cakar ^{[3
]}

Halim, M. Sohail ^{[2
]}

Hassan, Muhammad ^{[2
]}

Nguyen, Quan Dong ^{[2
]}

机构：

[1] Gazi Univ, Sch Med, Dept Ophthalmol, Ankara, Turkey

[2] Stanford Univ, Byers Eye Inst, Palo Alto, CA 94304 USA

[3] Univ Hlth Sci, Ulucanlar Eye Training & Res Hosp, Ankara, Turkey

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2021年 / 29卷 / 02期

关键词：

Fungal endogenous endophthalmitis; in-vitro fertilization; IVF; pars plana vitrectomy; pregnancy; CANDIDA ENDOPHTHALMITIS; RISK;

D O I：

10.1080/09273948.2019.1677917

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose: To report a Candida endogenous endophthalmitis in a pregnant woman with a prior history of in-vitro fertilization (IVF). Methods: Case report. Results: 21-year-old healthy woman within the first trimester of her pregnancy of a successful IVF developed a focal retinitis and panuveitis. Ocular findings suggested fungal endophthalmitis. The patient was treated with pars plana vitrectomy and repeated intravitreal antifungal injections. No systemic therapy was given. Cultures showed Candida albicans. IVF procedure was the only identifiable risk factor for endogenous endophthalmitis. Conclusions: In-vitro fertilization appeared as a possible risk factor for endogenous endophthalmitis during pregnancy. In the absence of systemic fungal infection, local intravitreal antifungal injections seem to be effective options to treat endogenous candida endophthalmitis, especially in the first trimester.

引用

页码：308 / 311

页数：4

共 50 条

[41] CUMULATIVE PREGNANCY RATES AND PREGNANCY OUTCOME AFTER IN-VITRO FERTILIZATION - GREATER-THAN-5000 CYCLES AT ONE CENTER
ALSALILI, M
YUZPE, A
TUMMON, I
PARKER, J
MARTIN, J
DANIEL, S
REBEL, M
NISKER, J
HUMAN REPRODUCTION, 1995, 10 (02) : 470 - 474
[42] Successful pregnancy after in-vitro fertilization and transmyometrial embryo transfer in a patient with congenital atresia of cervix
Anttila, L
Penttilä, TA
Suikkari, AM
HUMAN REPRODUCTION, 1999, 14 (06) : 1647 - 1649
[43] Establishment of a successful pregnancy following in-vitro fertilization with an endometrial thickness of no more than 4 mm
Sundström, P
HUMAN REPRODUCTION, 1998, 13 (06) : 1550 - 1552
[44] EFFECTS OF INDUCED HYPERPROLACTINEMIA ON IN-VITRO FERTILIZATION CYCLES
PIEKOS, MW
BINOR, Z
RAWLINS, RG
RADWANSKA, E
FERTILITY AND STERILITY, 1995, 63 (02) : 371 - 376
[45] The effect of anxiety and depression on the outcome of in-vitro fertilization
Smeenk, JMJ
Verhaak, CM
Eugster, A
van Minnen, A
Zielhuis, GA
Braat, DDM
HUMAN REPRODUCTION, 2001, 16 (07) : 1420 - 1423
[46] The ethics of using body mass index in in-vitro fertilization risk assessment
Williams, Valerie
BIOETHICS, 2023, 37 (09) : 879 - 885
[47] Dexamethasone during ovulation induction for in-vitro fertilization: A pilot study
Rein, MS
Jackson, KV
Sable, DB
Thomas, PP
Hornstein, MD
HUMAN REPRODUCTION, 1996, 11 (02) : 253 - 255
[48] In-Vitro Fertilization: A Study At Rural ART Clinic
More, Dipali
Choudhary, Namrata
Chimurkar, Vitas
Bhagat, Ashish
JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 82 - 90
[49] Exacerbation of hypertension during preparation for in-vitro fertilization a case study
Olszanecka, Agnieszka
Klocek, Marek
Milewicz, Tomasz
Krzysiek, Jozef
Kawecka-Jaszcz, Kalina
ARTERIAL HYPERTENSION, 2011, 15 (05): : 312 - 316
[50] THE EFFECT OF PENTOXIFYLLINE ON SPERM MOTILITY, OOCYTE FERTILIZATION, EMBRYO QUALITY, AND PREGNANCY OUTCOME IN AN IN-VITRO FERTILIZATION PROGRAM
DIMITRIADOU, F
RIZOS, D
MANTZAVINOS, T
ARVANITI, K
VOUTSINA, K
PRAPA, A
KANAKAS, N
FERTILITY AND STERILITY, 1995, 63 (04) : 880 - 886

← 1 2 3 4 5 →